Trexquant Investment’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $368K | Buy |
+15,266
| New | +$399K | ﹤0.01% | 1705 |
|
|
2025
Q2 | – | Sell |
-1,817,207
| Closed | -$46M | – | 1795 |
|
|
2025
Q1 | $46M | Buy |
1,817,207
+1,051,471
| +137% | +$27.5M | 0.54% | 13 |
|
|
2024
Q4 | $20.3M | Buy |
765,736
+43,193
| +6% | +$1.17M | 0.24% | 76 |
|
|
2024
Q3 | $20.9M | Sell |
722,543
-150,508
| -17% | -$4.39M | 0.26% | 75 |
|
|
2024
Q2 | $24.4M | Buy |
+873,051
| New | +$24M | 0.37% | 26 |
|
|
2023
Q1 | – | Sell |
-307,467
| Closed | -$15.8M | – | 1691 |
|
|
2022
Q4 | $15.8M | Buy |
+307,467
| New | +$14.7M | 0.45% | 31 |
|
|
2022
Q2 | – | Sell |
-109,769
| Closed | -$5.68M | – | 1777 |
|
|
2022
Q1 | $5.68M | Buy |
+109,769
| New | +$5.7M | 0.27% | 91 |
|
|
2021
Q4 | – | Sell |
-153,512
| Closed | -$6.6M | – | 1553 |
|
|
2021
Q3 | $6.6M | Sell |
153,512
-6,940
| -4% | -$307K | 0.52% | 22 |
|
|
2021
Q2 | $6.28M | Buy |
+160,452
| New | +$6.24M | 0.53% | 29 |
|
|
2021
Q1 | – | Sell |
-88,745
| Closed | -$3.27M | – | 1379 |
|
|
2020
Q4 | $3.27M | Sell |
88,745
-67,571
| -43% | -$2.48M | 0.35% | 70 |
|
|
2020
Q3 | $5.44M | Sell |
156,316
-12,729
| -8% | -$446K | 0.35% | 53 |
|
|
2020
Q2 | $5.25M | Buy |
169,045
+142,725
| +542% | +$4.85M | 0.36% | 45 |
|
|
2020
Q1 | $815K | Sell |
26,320
-137,245
| -84% | -$4.68M | 0.06% | 486 |
|
|
2019
Q4 | $6.08M | Buy |
163,565
+42,358
| +35% | +$1.51M | 0.36% | 71 |
|
|
2019
Q3 | $4.13M | Buy |
+121,207
| New | +$4.41M | 0.36% | 79 |
|
|
2018
Q3 | – | Sell |
-7,414
| Closed | -$255K | – | 1136 |
|
|
2018
Q2 | $255K | Buy |
+7,414
| New | +$253K | 0.02% | 726 |
|
|
2018
Q1 | – | Sell |
-26,520
| Closed | -$911K | – | 1304 |
|
|
2017
Q4 | $911K | Buy |
+26,520
| New | +$904K | 0.1% | 319 |
|
|
2017
Q3 | – | Sell |
-15,283
| Closed | -$487K | – | 970 |
|
|
2017
Q2 | $487K | Buy |
15,283
+6,429
| +73% | +$203K | 0.13% | 260 |
|
|
2017
Q1 | $287K | Buy |
+8,854
| New | +$279K | 0.04% | 778 |
|
|
2016
Q3 | – | Sell |
-45,638
| Closed | -$1.52M | – | 933 |
|
|
2016
Q2 | $1.52M | Buy |
+45,638
| New | +$1.46M | 0.2% | 143 |
|
|
2015
Q3 | – | Sell |
-31,515
| Closed | -$1M | – | 1212 |
|
|
2015
Q2 | $1M | Buy |
+31,515
| New | +$1.03M | 0.11% | 320 |
|
|
2015
Q1 | – | Sell |
-32,252
| Closed | -$953K | – | 1134 |
|
|
2014
Q4 | $953K | Buy |
+32,252
| New | +$925K | 0.17% | 180 |
|
Other funds holding PFE
Trexquant Investment's PFE Position: Q2 2026 in Review
Trexquant Investment opened a new position in Pfizer (PFE) in Q2 2026: 15,266 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #1705 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in PFE as recently as Q1 2025.
Trexquant Investment first reported a position in PFE in Q4 2014 and has held it in 22 quarters since. The position peaked at $46M in Q1 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Trexquant Investment held 15,266 shares of Pfizer worth $368K as of Q2 2026.
- Pfizer was a new Trexquant Investment position in Q2 2026.
- Pfizer made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1705 holding.
- Trexquant Investment first reported a position in Pfizer in Q4 2014 and has held it in 22 quarters since.
- Trexquant Investment's Pfizer position peaked at $46M in Q1 2025.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.